HGH vs tesamorelin compared: FDA approval, how each raises growth hormone, typical dosing, cost, side effects, and questions to ask a healthcare provider.
HGH and tesamorelin both increase growth hormone signaling, but they are not interchangeable. HGH (somatropin) is recombinant human growth hormone that you inject directly, while tesamorelin is a growth hormone-releasing hormone (GHRH) analog that tells your pituitary gland to release more of your own GH. Both are prescription drugs in the United States, and neither is FDA-approved for general weight loss or anti-aging.
That replace-versus-stimulate difference explains nearly every other contrast in this comparison: dosing, blood-test monitoring, side effects, price, and what a doctor is legally allowed to prescribe them for.
HGH vs Tesamorelin at a Glance
| Factor | HGH (somatropin) | Tesamorelin (Egrifta) |
|---|---|---|
| Category | Recombinant hormone | Synthetic GHRH peptide |
| How it works | Adds GH directly to the bloodstream | Stimulates pituitary GH release |
| FDA-approved for | GH deficiency, HIV wasting, short stature, other specific conditions | Visceral fat reduction in HIV-associated lipodystrophy |
| Typical adult dose | 0.1-1 mg daily, individualized | 1.4 mg or 2 mg once daily |
| Common side effects | Swelling, joint pain, carpal tunnel, insulin resistance | Injection-site reactions, joint and muscle pain |
| Lab monitoring | IGF-1, glucose, thyroid | IGF-1, glucose |
How Each One Raises Growth Hormone
HGH is a finished hormone. Once injected, it circulates and stimulates the liver and other tissues to produce insulin-like growth factor 1 (IGF-1), the main driver of many of its effects on muscle, fat, and connective tissue.
Tesamorelin works one step earlier. It binds GHRH receptors in the pituitary, prompting the gland to release its own growth hormone in a more natural, pulsatile pattern. Because tesamorelin depends on a functioning pituitary, it is generally not used in people with pituitary disease or damage.
A practical consequence: exogenous HGH can suppress your body's own GH production over time, while tesamorelin is designed to work with it rather than replace it.
FDA Approval and Legal Status
Both drugs are legal only by prescription in the US, and each has a narrow approved label.
- HGH (somatropin): approved for pediatric and adult growth hormone deficiency, short stature from specific causes, HIV-associated wasting, and a few other conditions.
- Tesamorelin: approved in 2010 as Egrifta (now Egrifta WR) solely to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
HGH is not FDA-approved for anti-aging, athletic performance, or general fat loss, and using it for those purposes is off-label. Tesamorelin is not approved as a general weight-loss drug, and it is not approved for people who are HIV-negative.
Buying either drug from an overseas pharmacy or a "research chemical" vendor means skipping FDA oversight, potency testing, and sterility checks. Many people who go that route also look at how sermorelin vs tesamorelin protocols differ, since both peptides move through the same gray-market channels.
Dosing, Cost, and Access
Dosing looks similar on paper, since both are subcutaneous injections, but the day-to-day experience is different.
- HGH: dosed in international units or milligrams, usually once daily at night and titrated based on IGF-1 levels and side effects. Brand pens commonly list for roughly $1,500 to $3,500 per month in the US without insurance.
- Tesamorelin: a fixed 1.4 mg or 2 mg daily dose. List prices for Egrifta have historically run in the low thousands of dollars per month, and insurers often require documented HIV lipodystrophy before covering it.
Cost is usually the deciding factor for people paying out of pocket. Compounded somatropin and compounded peptides can cost less, but compounded products are not FDA-approved and vary in quality.
Another frequent comparison point is mk677 vs tesamorelin, because MK-677 is an oral ghrelin mimetic that raises GH through a third pathway entirely. It requires no injection, but it also has no FDA approval for any human use.
Side Effects and Safety
Because HGH delivers a fixed amount of hormone, it is easier to overshoot normal physiology. Common issues include:
- Fluid retention, swollen hands and feet, and joint pain
- Carpal tunnel syndrome
- Insulin resistance and elevated blood sugar
- Persistently high IGF-1, which some research links to increased risk of certain cancers
Tesamorelin's most common complaints are injection-site reactions, joint pain, and muscle aches. It can also raise IGF-1 and affect blood sugar, so lab monitoring is still required.
Neither drug is appropriate during pregnancy, and both are generally avoided in people with active cancer. A doctor should review your history, medications, and labs before either is considered.
If fat reduction is the actual goal rather than growth hormone output, discussions like aod 9604 vs hgh frag 176-191 are more relevant, since those peptides target fat metabolism directly instead of raising GH.
What Reddit Threads Get Right and Wrong
Interest in tesamorelin vs hgh reddit discussions usually centers on fat loss, cost, and whether one "works better." The honest answer is that they are not substitutes: HGH replaces a hormone, and tesamorelin stimulates its production.
Anecdotes about dramatic fat loss often involve supraphysiologic HGH doses that carry real metabolic risk, or unverified peptides with unknown purity. User reports are not clinical evidence, and the FDA-approved tesamorelin trials enrolled people with HIV lipodystrophy, not healthy adults chasing a leaner physique.
People who search igf-1 lr3 vs tesamorelin reddit are usually comparing a downstream growth factor with an upstream releasing hormone, which is not an apples-to-apples swap at all.
For anyone weighing cjc-1295 ipamorelin vs tesamorelin, the key distinction is half-life and dosing frequency rather than a difference in end goal. All three aim to nudge pituitary output upward, not to replace the hormone outright.
Bottom Line
HGH is a direct hormone replacement with a broad approved label but meaningful metabolic risks and a high price. Tesamorelin is a narrower, more physiologic stimulator that is FDA-approved for one specific condition.
Neither is a casual fat-loss tool, and both require a prescription, bloodwork, and medical supervision. Talk to a healthcare professional before starting, stopping, or sourcing either compound.
Frequently Asked Questions
Is tesamorelin basically the same as HGH?
No. Tesamorelin is a GHRH analog that signals your pituitary to release more of your own growth hormone, while HGH is lab-made growth hormone injected directly into the body. Tesamorelin produces a smaller, more pulsatile rise in GH and IGF-1 than a full replacement dose of HGH.
Does tesamorelin burn belly fat in people who are HIV-negative?
Tesamorelin is FDA-approved only for visceral fat reduction in adults with HIV-associated lipodystrophy, and that is the population studied in its clinical trials. Some small studies have looked at tesamorelin in other groups, but it is not approved for general weight loss, and off-label use still requires a prescription and monitoring.
Can you stack HGH and tesamorelin together?
There is no solid clinical evidence supporting combined use, and the two drugs overlap in what they do. Taking both can push IGF-1 and blood sugar higher than either alone, increasing the risk of swelling, joint pain, and insulin resistance, so stacking should only be considered under close medical supervision.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.